Le Lézard
Classified in: Health, Business
Subject: PER

International Medical Group Appoints Steve Paraboschi as Executive Vice President



INDIANAPOLIS, Oct. 5, 2017 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning international medical and travel insurance company, is pleased to announce that Steve Paraboschi has joined the company as executive vice president.

International Medical Group (IMG) is an award-winning international medical and travel insurance company.

Paraboschi will be responsible for P&L across the company and support of IMG's international insurance distribution and operations.

"IMG is a market leader whose rapid global growth, innovative product solutions and steadfast commitment to being there for its customers set it apart from competitors," Paraboschi said. "I'm thrilled to join IMG at such an exciting time in the company's history, and look forward to working with its outstanding leadership team to further the company's international reputation for excellence."

Paraboschi comes to IMG from AXA Assistance USA, where he served as the chief executive officer, managing a profitable P&L, driving alignment and global strategies, and developing innovative product distribution methods.

Previously, as the general manager and vice president of AXA Assistance USA's Global Healthcare TPA and Travel Services business, Paraboschi spearheaded the development of a travel risk management product, directed successful market entries, improved bottom line performance, and led revenue growth of 110% over five years.

Prior to his time at AXA, Paraboschi worked at The Guardian Life Insurance Company and MetLife. He currently serves on the Board of Directors for the U.S. Travel Insurance Association and the French American Chamber of Commerce of Chicago.

"We are pleased to welcome Steve to the IMG team," said President and CEO Brian Barwick. "He has a proven track record of developing business strategies that drive top line and bottom line growth, while supporting a dynamic environment of teamwork and employee development. His customer-focused and results-oriented approach, combined with his industry expertise, make him distinctly qualified to serve as IMG's executive vice president."

About International Medical Group
International Medical Group® (IMG®), a Sirius Group company, is an award-winning international medical and travel insurance company that has served millions of members worldwide since its founding in 1990. A leader in the global benefits and assistance services industry, IMG offers a full line of international medical insurance products, as well as travel insurance plans, medical management services and 24/7 emergency medical and travel assistance. For more information, please visit www.imglobal.com.

Logo - http://mma.prnewswire.com/media/564172/IMG_Logo_2016_TM_Logo.jpg 


These press releases may also interest you

at 08:00
Synthetic Biology Market is forecast to reach $8.84 billion by 2022 from $3.57 billion in 2017 at a CAGR of 19.9% during (2017-2022) driven by the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand...

at 08:00
The Corrona® Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC, the leading sponsor of registries in autoimmune and immune-mediated diseases, announces it has expanded into Canada and has...

at 08:00
OncoTartis, Inc., a biotechnology company developing a novel category of anti-cancer drugs, has concluded a $6 million financing round to support the Phase 1 clinical trial of its lead drug candidate, OT-82.  Participants in the round included Norma...

at 08:00
Sophiris Bio Inc. (the "Company" or "Sophiris") today announced that it has completed enrollment in its Phase 2b study to evaluate the safety and tolerability of topsalysin in treating men with clinically significant localized prostate cancer....

at 08:00
Cardiome Pharma Corp. , a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today highlighted that its partner SteadyMed Therapeutics has reached agreement with the U.S. Food and Drug Administration...

at 08:00
The "Human Identification Market - Global Forecast to 2022" report has been added to Research and Markets' offering. Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology with DNA...




News published on 5 october 2017 at 10:00 and distributed by: